Shockwave Medical, Inc. Common Stock
SWAV
SWAV was delisted on the 30th of May, 2024.
266 hedge funds and large institutions have $6.64B invested in Shockwave Medical, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 52 funds opening new positions, 93 increasing their positions, 83 reducing their positions, and 23 closing their positions.
126% more first-time investments, than exits
New positions opened: 52 | Existing positions closed: 23
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
50% more call options, than puts
Call options by funds: $81.5M | Put options by funds: $54.3M
12% more repeat investments, than reductions
Existing positions increased: 93 | Existing positions reduced: 83
11% more funds holding
Funds holding: 240 → 266 (+26)
9% more capital invested
Capital invested by funds: $6.11B → $6.64B (+$534M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$138M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$42.5M |
| 3 |
Morgan Stanley
New York
|
+$24M |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$15.9M |
| 5 |
CA
CastleArk Alternatives
Chicago,
Illinois
|
+$12.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$62.3M |
| 2 |
JP Morgan Chase
New York
|
-$51.2M |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$39.7M |
| 4 |
Barclays
London,
United Kingdom
|
-$37.1M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$25.6M |
SWAV Hedge Fund Activity: Q3 2021 in Review
266 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Shockwave Medical, Inc. Common Stock (SWAV) for Q3 2021, worth a combined $6.64B — up 8.7% from $6.11B a quarter earlier.
Buyers outnumbered sellers: 52 funds opened new SWAV positions and 23 closed out — a net gain of 29 holders — while 93 added to existing stakes and 83 trimmed.
The largest buyer was Invesco, adding an estimated $138M. The largest seller was Lord, Abbett & Co, cutting an estimated $62.3M.
- 266 institutional investors held Shockwave Medical, Inc. Common Stock (SWAV) as of Q3 2021, up from 240 in Q2 2021.
- Funds reported $6.64B of Shockwave Medical, Inc. Common Stock stock for Q3 2021, up 8.7% quarter-over-quarter.
- 52 funds opened new Shockwave Medical, Inc. Common Stock positions in Q3 2021 and 23 closed out, a net change of +29 holders.
- The largest Shockwave Medical, Inc. Common Stock buyer in Q3 2021 was Invesco, an estimated $138M added.
- The largest Shockwave Medical, Inc. Common Stock seller in Q3 2021 was Lord, Abbett & Co, an estimated $62.3M sold.
Based on aggregated 13F filings for Q3 2021.